▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #310 by analyst upside · 2026-11-07
ACH
Accendra Health, Inc.
Healthcare · Market Cap $16M · P/E 0x
ANALYST PRICE TARGET
+521.6%
implied upside to consensus target
Current Price $0.2
Consensus Target $1.26
Bull Target $1.75
Bear Target $0.5
Analysts Covering 4
ANALYST CONSENSUS - UNDERPERFORM
Strong Buy
0
Buy
0
Hold
2
Sell
2
52-Week Low $0.19
52-Week High $4.69
YTD Return -91.4%
FUNDAMENTALS
Market Cap $16M
P/E Ratio (TTM) N/A
Forward P/E 2.4x
EPS (TTM) $-1.60
PEG Ratio 0.70
Dividend Yield N/A
Revenue (TTM) $2.6B
Profit Margin -6.7%
52-WEEK RANGE
52-Week Low $0.19
52-Week High $4.69
Current Price $0.2
Bear Target $0.5
Bull Target $1.75
● Now $0.2 ● Target $1.26
TRADING DATA
Avg Volume 2.5M
YTD Return -91.4%
Analyst Count 4
Consensus Underperform
Upside to Target +521.6%
Last Updated 2026-11-07

ANALYST SUMMARY

Accendra Health, Inc. (ACH) is currently trading at $0.2 with a Wall Street consensus price target of $1.26, implying potential upside of 521.6% over the next 12 months. 4 analysts currently cover ACH, with a consensus rating of Underperform - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1.75, while the most cautious has a target of $0.5.

ACH operates in the Healthcare sector with a market capitalisation of $16M. The stock is down 91.4% year-to-date and is currently trading near the lower end of its 52-week range of $0.19 – $4.69.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ACH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Neutral → Neutral 2026-08-13 33% win rate (6 calls)
Citigroup ↓ Downgrade
Buy → Neutral 2026-08-11 Building track record
Citigroup - Reiterated
Buy → Buy 2026-07-24 Building track record
UBS - Reiterated
Neutral → Neutral 2026-05-12 33% win rate (6 calls)
Citigroup - Reiterated
Buy → Buy 2026-05-12 Building track record
Baird - Reiterated
Outperform → Outperform 2026-05-12 Building track record
Leerink Partners - Reiterated
Market Perform → Market Perform 2026-02-20 29% win rate (7 calls)
Citigroup - Reiterated
Buy → Buy 2026-01-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
14
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →